As a bonus, Bavarian Nordic also gets a priority review voucher from the FDA, awarded as an incentive to carry out drug ...
9h
GlobalData on MSNBavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teensBavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.
Bavarian Nordic (BN) announced that the US Food and Drug Administration (FDA) has approved its recombinant ...
The Ministry of Public Health (MSP) highlighted its ongoing efforts to prevent, control, and eliminate tropical diseases such ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...
Ahmedabad: The city recorded 203 cases of diarrhoea, 84 cases of jaundice, 123 typhoid cases, and one case of cholera between ...
Shares in the UK's IP Group slid today after it revealed that an arthritis drug in development at one of its portfolio ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...
Satellites, as part of their Earth observation tasks, can monitor public health threats and assess risks for people living in ...
EU mid-market update: Europe grapples with Ukraine and tariff risks; US and Canada closed for holiday; German elections next ...
Advances in medical sciences have reduced infectious disease mortality, but emerging pathogens pose global health threats.
The General Directorate of Epidemiology reported low incidences of dengue, cholera, and leptospirosis, as can be seen in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results